RLP-2 TZ 15 MG

Retatrutide is a unimolecular tri-agonist targeting GLP-1, GIP, and GCGR, supplied for advanced metabolic research on energy expenditure, glycemic control mechanisms, and hepatometabolic signaling.

Research-Only Use:
This material is not intended for human consumption, clinical use, or veterinary applications. No claims are made regarding safety or efficacy for in vivo purposes or applications.
Disclaimer:
The information presented here is not intended to diagnose, treat, cure, or prevent any disease, it is provided for scientific purposes only. Statements have not been evaluated by any regulatory authority. Product use is restricted to qualified researchers or institutions in compliance with local state and federal law(s).
Terms of Sale:
By purchasing this item, you confirm that you are a qualified researcher, institution, or laboratory operating within legally-permitted research guidelines. We shall not be held liable for any loss, injury, claim, or damage resulting from misuse, improper handling, unauthorized application, or illegal distribution of any item purchased.